News Finding: Their research indicates that stem cell therapy could pave the way to engineer the cells and provide a superior form of treatment, possibly using various types of cells to treat different symptoms of Parkinson's disease including memory loss and impaired movement.
Paper Finding: They also identified three zones: amnion, Wharton's jelly and vessel walls within the cord, and showed arterial perivascular jelly of about 650 microns depth before and after digestion.
News Context: The authors of the study, Dr. Claire Henchcliffe and Malin Parmar, Ph.D., believe that the medical world is moving into a very exciting era for stem cell therapy. Their research indicates that stem cell therapy could pave the way to engineer the cells and provide a superior form of treatment, possibly using various types of cells to treat different symptoms of Parkinson's disease including memory loss and impaired movement. Thanks to massive strides in technology, the authors of this study also believe that cell replacement may hold the potential to alleviate all motor symptoms, if not more symptoms for Parkinson's disease, in the decades to come.
Paper Context: specifically distinguished between in situ umbilical cord stromal stem cells (isUCSSC) and cultured UCSSC. They also identified three zones: amnion, Wharton's jelly and vessel walls within the cord, and showed arterial perivascular jelly of about 650 microns depth before and after digestion. Indeed, Farias et al.